Business
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in May
NAARDEN, the Netherlands and MIAMI, May 11, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that company management will participate in the fo
About this update from Newamsterdam Pharma Company N.v.
[{"type":"image","alt":"NewAmsterdam Pharma N.V.","displaySize":"","headline":null,"caption":"NewAmsterdam Pharma N.V.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":75,"url":"https://media.zenfs.com/en/globenewswire.com/7a9e14494624e24d3616c1924c4ac204"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/QUPiMxJV13vlog5_jQhF2g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwNQ--/https://media.zenfs.com/en/globenewswire.com/7a9e14494624e24d3616c1924c4ac204","width":300,"height":75},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/QUPiMxJV13vlog5_jQhF2g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwNQ--/https://media.zenfs.com/en/globenewswire.com/7a9e14494624e24d3616c1924c4ac204","width":300,"height":75}},"lazy":false},{"type":"text","content":"NAARDEN, the Netherlands and MIAMI, May 11, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that company management will participate in the following upcoming investor conferences:","length":538,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"BofA Securities 2026 Health Care Conference in Las Vegas, NV on Tuesday, May 12, 2026. Ian Somaiya, Chief Financial Officer, BJ Jones, Chief Commercial Officer, and Matthew Philippe, Executive Vice President, Head of Investor Relations, will participate in a fireside chat at 5:15 p.m. PT on Tuesday, May 12.","length":313,"tagName":"p"}]},{"val":[{"type":"text","content":"2026 RBCCM Global Healthcare Conference in New York, NY on Wednesday, May 20, 2026. Michael Davidson, M.D., Chief Executive Officer, and Matthew Philippe, Executive Vice President, Head of Investor Relations, will participate in a fireside chat at 2:05 p.m. ET on Wednesday, May 20.","length":287,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":600,"olType":false},{"type":"text","content":"Live webcasts of both presentations will be available through the investor relations section of the NewAmsterdam Pharma website at ir.newamsterdampharma.com. Following the live webcasts, archived repla...